These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1321649)
1. Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm Mammography Screening Project. von Rosen A; Frisell J; Nilsson R; Wiege M; Auer G Acta Oncol; 1992; 31(4):399-402. PubMed ID: 1321649 [TBL] [Abstract][Full Text] [Related]
2. DNA ploidy in screening-detected non-palpable mammary carcinomas. von Rosen A; Frisell J; Azavedo E; Auer G Eur J Surg Oncol; 1990 Dec; 16(6):471-4. PubMed ID: 2174806 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen. Stomper PC; Stewart CC; Penetrante RB; Nava ME; Tsangaris TN Radiology; 1992 Nov; 185(2):415-22. PubMed ID: 1329141 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis of specimen mammography-guided fine-needle aspirates of ductal carcinoma in situ. Stomper PC; DeBloom JR; Winston JS; Stewart CC J Exp Clin Cancer Res; 2000 Sep; 19(3):309-15. PubMed ID: 11144524 [TBL] [Abstract][Full Text] [Related]
5. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas. Azavedo E; Fallenius A; Svane G; Auer G Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920 [TBL] [Abstract][Full Text] [Related]
6. Assessment of malignancy potential in so-called interval mammary carcinomas. von Rosen A; Erhardt K; Hellström L; Somell A; Auer G Breast Cancer Res Treat; 1985; 6(3):221-7. PubMed ID: 3004621 [TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
8. DNA ploidy in intraductal breast carcinomas. Aasmundstad TA; Haugen OA Eur J Cancer; 1990; 26(9):956-9. PubMed ID: 2177615 [TBL] [Abstract][Full Text] [Related]
9. Biennial versus annual mammography and the risk of late-stage breast cancer. White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639 [TBL] [Abstract][Full Text] [Related]
10. Improved detection rate of early breast cancer in mass screening combined with mammography. Ohuchi N; Yoshida K; Kimura M; Ouchi A; Kamioki S; Shiiba K; Matoba N; Kojima S; Takahashi K; Matsuno S Jpn J Cancer Res; 1993 Jul; 84(7):807-12. PubMed ID: 8396569 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of raster mammography and real time sonography with histology in carcinoma of the breast]. Stauch G; Majewski A; Pollak F; Hilfrich J Rofo; 1988 Oct; 149(4):402-7. PubMed ID: 2845509 [TBL] [Abstract][Full Text] [Related]
13. [Clinical x-ray and morphological changes in breast carcinomas during radiothermotherapy]. Pugachev VF; Terent'eva NA; Torgushina NS; Rumiantsev AB; Sumina TV Vopr Onkol; 1989; 35(11):1352-4. PubMed ID: 2558443 [TBL] [Abstract][Full Text] [Related]
14. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214 [TBL] [Abstract][Full Text] [Related]
15. Specimen mammography distorts margin status in patients undergoing breast conserving surgery for early-stage breast cancer. Ota K; Rivera C; Martin M Breast J; 2017 Nov; 23(6):760-761. PubMed ID: 28914462 [No Abstract] [Full Text] [Related]
16. Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Obdeijn IM; Loo CE; Rijnsburger AJ; Wasser MN; Bergers E; Kok T; Klijn JG; Boetes C Breast Cancer Res Treat; 2010 Jan; 119(2):399-407. PubMed ID: 19876732 [TBL] [Abstract][Full Text] [Related]
17. Nonpalpable breast masses: radiologic predictability of malignancy. Hermann G; Keller RJ; Schwartz IS; Papatestas A; Rajagopalan B; Rabinowitz JG Can Assoc Radiol J; 1990 Jun; 41(3):130-2. PubMed ID: 2162236 [TBL] [Abstract][Full Text] [Related]
18. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ; Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248 [TBL] [Abstract][Full Text] [Related]
19. Mitotic rate, DNA distribution, and chromatin in situ sensitivity to heparin in breast cancer. Weiss H; Brasching HP; Bock A; Mauthner F; Peek U Breast Cancer Res Treat; 1990 Jul; 16(1):41-50. PubMed ID: 2169927 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS. Saito M; Matsuzaki M; Sakuma T; Katagata N; Watanabe F; Yamaguchi Y; Schetter AJ; Takenoshita S; Nomizu T Breast Cancer; 2014 Mar; 21(2):140-5. PubMed ID: 22875640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]